ARCHIVES

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013